Lead product GelrinC®, a hydrogel synchronized erosion and resorbable implant, the only restorative product for knee ...
Founded in 2009, Tides has evolved from a distributor of birth-tissue products into a biotechnology platform focused on ...
CCRM and CCRM Nordic AB have announced a strategic collaboration with IonQ, a global leader in quantum computing technologies ...
TipRanks on MSN
Immix Biopharma announces positive phase 2 trial results
The latest announcement is out from Immix Biopharma ( (IMMX) ).
Diana Hussain, MD, FAAPMR, DABPM Florida Wellness & Regenerative Medicine ABOUT THE DOCTOR Dr. Diana Hussain completed her ...
Biodegradable Microspheres Market to reach USD 8.1 Bn by 2035, growing at a 8.9% CAGR, driven by rising use in drug delivery ...
The Global Bio Preservation Market presents growth opportunities driven by the rising demand for organ transplants and ...
The Wyss Institute is proud to welcome three new Associate Faculty members: Ahmad (Mo) Khalil, Ph.D., Jarad Mason, Ph.D., and Chao-ting (Ting) Wu, Ph.D. Each has a history of collaborating with the ...
Investing.com -- Lyell Immunopharma Inc (NASDAQ:LYEL) stock rose 4.2% in premarket trading Monday after the clinical-stage biotech company reported promising data from its cancer therapy trials.
Regenerative medicine offers a promising, accessible option for those seeking better mobility, reduced inflammation, stronger ...
Pilot program addresses critical evidence gap in emerging regenerative medicine treatments for 32.5 million Americans with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback